Literature DB >> 29108929

Development of a New ICT-Based Multisensor Blood Pressure Monitoring System for Use in Hemodynamic Biomarker-Initiated Anticipation Medicine for Cardiovascular Disease: The National IMPACT Program Project.

Kazuomi Kario1, Naoko Tomitani2, Hiroshi Kanegae3, Nobuhiko Yasui4, Masafumi Nishizawa5, Takeshi Fujiwara6, Takeya Shigezumi7, Ryozo Nagai8, Hiroshi Harada9.   

Abstract

We have developed a multisensor home and ambulatory blood pressure (BP) monitoring system for monitoring 24-h central and brachial BP variability concurrent with physical activity (PA), temperature, and atmospheric pressure. The new BP monitoring system utilizes our recently developed biological and environmental signal monitoring Information Communication Technology/Internet of Things system, which can simultaneously monitor the environment (temperature, illumination, etc.) of different rooms in a house (entryway, bedroom, living room, bathing room, and toilet), and a wrist-type high-sensitivity actigraph for identifying the location of patients. By collecting both data on BP and environmental parameters, the system can assess the brachial and central hemodynamic BP reactivity profiles of patients, such as actisensitivity (BP change with PA), thermosensitivity (with temperature), and atmospheric sensitivity (with atmospheric pressure). We used this new system to monitor ambulatory BP variability in outpatients with one or more cardiovascular disease (CVD) risk factors both in summer and winter. Actisensitivity (the slope of the regression line of ambulatory BP against the log-physical activity) was higher in winter than summer. By multi-level analysis using the parameters monitored by this system, we estimated the ambulatory BPs under different conditions. The individual time-series big data collected by this system will contribute to anticipation medicine for CVD.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ambulatory blood pressure monitoring; Anticipation medicine; Blood pressure variability; Home blood pressure monitoring; Information and communication technology (ICT); Internet of Things (IoT); Physical activity; Thermosensitive; Time-series big data

Mesh:

Year:  2017        PMID: 29108929     DOI: 10.1016/j.pcad.2017.10.002

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  34 in total

1.  Association of Cardiovascular Outcomes With Masked Hypertension Defined by Home Blood Pressure Monitoring in a Japanese General Practice Population.

Authors:  Takeshi Fujiwara; Yuichiro Yano; Satoshi Hoshide; Hiroshi Kanegae; Kazuomi Kario
Journal:  JAMA Cardiol       Date:  2018-07-01       Impact factor: 14.676

Review 2.  Impact of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines on the Next Blood Pressure Guidelines in Asia.

Authors:  Naoki Nakagawa; Naoyuki Hasebe
Journal:  Curr Hypertens Rep       Date:  2019-01-10       Impact factor: 5.369

3.  Diagnostic accuracy of an algorithm for detecting atrial fibrillation in a wrist-type pulse wave monitor.

Authors:  Tomoyuki Kabutoya; Shinichi Takahashi; Tomonori Watanabe; Yasushi Imai; Kazuhiro Uemoto; Nobuhiko Yasui; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-08-17       Impact factor: 3.738

4.  Systemic hemodynamic atherothrombotic syndrome (SHATS): Diagnosis and severity assessment score.

Authors:  Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-04-22       Impact factor: 3.738

5.  The further development of out-of-office BP monitoring: Japan's ImPACT Program Project's achievements, impact, and direction.

Authors:  Kazuomi Kario; Naoko Tomitani; Hiroshi Kanegae; Nobuhiko Yasui; Ryozo Nagai; Hiroshi Harada
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-02-27       Impact factor: 3.738

Review 6.  Diversity of and initiatives for hypertension management in Asia-Why we need the HOPE Asia Network.

Authors:  Kazuomi Kario; Yook-Chin Chia; Apichard Sukonthasarn; Yuda Turana; Jinho Shin; Chen-Huan Chen; Peera Buranakitjaroen; Jennifer Nailes; Satoshi Hoshide; Saulat Siddique; Jorge Sison; Arieska Ann Soenarta; Guru Prasad Sogunuru; Jam Chin Tay; Boon Wee Teo; Yu-Qing Zhang; Sungha Park; Huynh Van Minh; Naoko Tomitani; Tomoyuki Kabutoya; Narsingh Verma; Tzung-Dau Wang; Ji-Guang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-11-26       Impact factor: 3.738

Review 7.  The influence of the ambient temperature on blood pressure and how it will affect the epidemiology of hypertension in Asia.

Authors:  Sungha Park; Kazuomi Kario; Yook-Chin Chia; Yuda Turana; Chen-Huan Chen; Peera Buranakitjaroen; Jennifer Nailes; Satoshi Hoshide; Saulat Siddique; Jorge Sison; Arieska Ann Soenarta; Guru Prasad Sogunuru; Jam Chin Tay; Boon Wee Teo; Yu-Qing Zhang; Jinho Shin; Huynh Van Minh; Naoko Tomitani; Tomoyuki Kabutoya; Apichard Sukonthasarn; Narsingh Verma; Tzung-Dau Wang; Ji-Guang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-12-18       Impact factor: 3.738

8.  Expert panel consensus recommendations for ambulatory blood pressure monitoring in Asia: The HOPE Asia Network.

Authors:  Kazuomi Kario; Jinho Shin; Chen-Huan Chen; Peera Buranakitjaroen; Yook-Chin Chia; Romeo Divinagracia; Jennifer Nailes; Satoshi Hoshide; Saulat Siddique; Jorge Sison; Arieska Ann Soenarta; Guru Prasad Sogunuru; Jam Chin Tay; Boon Wee Teo; Yuda Turana; Yuqing Zhang; Sungha Park; Huynh Van Minh; Ji-Guang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-09       Impact factor: 3.738

9.  Validation of two watch-type wearable blood pressure monitors according to the ANSI/AAMI/ISO81060-2:2013 guidelines: Omron HEM-6410T-ZM and HEM-6410T-ZL.

Authors:  Mitsuo Kuwabara; Kanako Harada; Yukiko Hishiki; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-02-25       Impact factor: 3.738

Review 10.  The HOPE Asia Network activity for "zero" cardiovascular events in Asia: Overview 2020.

Authors:  Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-02-24       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.